The ARID II trial investigates the Voro Urologic Scaffold's safety and efficacy in prostate cancer patients undergoing robotic-assisted radical prostatectomy. The scaffold aims to improve urinary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback